Treatment Action Group

Tweet this page
<
2023
2024
>
Registration as it was on 30 Sep 2024
How to read and use this data card.
Download this datacard

Overview

Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

Lobbying Costs

None declared

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

0.35 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Treatment Action Group   (TAG)

    EU Transparency Register

    916467249117-03 First registered on 16 Feb 2023

    Goals / Remit

    Treatment Action Group (TAG) envisions the end of the HIV, tuberculosis (TB), and hepatitis C (HCV) pandemics with the discovery, development, and worldwide dissemination of safe and effective diagnostics, preventives, and cures through public health structures that end systemic harms and promote human rights, and that are developed by the diverse communities most affected by these conditions. This vision will be realized based on data and science, and achieved through community engagement, distributive justice, and equitable access to the benefits of science.

    Main EU files targeted

    EU Global Health Strategy; Horizon Europe R&I policies; EU policies on antimicrobial resistance and other health research.

    Address

    Head Office
    90 Broad StSuite 2503
    New York 10004
    UNITED STATES
    EU Office
    90 Broad StSuite 2503
    New York 10004
    UNITED STATES

    Website

    https://www.treatmentactiongroup.org/

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%1
    10%1

    Lobbyists (Full time equivalent)

    0.35

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Non-governmental organisations, platforms and networks and similar

  • Networking

    Affiliation

    TAG is a member of the Washington, D.C.-based Global Health Technologies Coalition (https://www.ghtcoalition.org/our-members). TAG is also a member of the Stop TB Partnership, hosted by UNOPS and based in Geneva, Switzerland (https://stoptb.org/partners/).

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Does not represent commercial interests

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.

    Total organisational budget in closed year

    4,680,938€

    Major funding types in closed year

    Donations, Grants, Public funding

    Major contributions in closed year

    TypeNameAmount
    Contribution Johns Hopkins School of Medicine 620,037€
    Contribution Bill & Melinda Gates Foundation 793,855€

    Other financial info

    Please note that the estimate of annual costs related to activities covered by the Register is estimated to be very low as Treatment Action Group (TAG) is a USA-based organization that engages with the EU on narrow, discrete topics and not as a matter of our primary mission. Our engagement is limited to EU policies and programmes related to global health research, specifically within the sub-field of infectious diseases and primarily focused on tuberculosis (TB). Estimates of staff time reflect reasonable estimates of effort given to these activities and to supervising the work of a Brussels-based consultant, Karen Hoehn of Bonstar Consulting, with whom TAG has a contractual relationship to outsource relevant representation activities. Our contract with Karen Hoehn totals USD $24,000 (~EUR 22,100) for the period February 2024 through December 2024, subject to renewal at similar level of effort.

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    TAG publishes an annual report on global funding for tuberculosis research and development (R&D), which contains analysis of and information on EU funding for TB R&D (https://www.treatmentactiongroup.org/resources/tbrd-report/). TAG publishes an an annual report tracking the clinical development pipelines of new vaccines, diagnostics, and treatments for TB, HIV, and viral hepatitis, some of which are funded by EU institutions (https://www.treatmentactiongroup.org/resources/pipeline-report/2024-pipeline-report/).

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

Download this datacard